(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(((3-phenylacryloyl)oxy)methyl)tetrahydro-2H-pyran-2-yl 3,4,5-trihydroxybenzoate

Catalog No. :
ACMNZL328
CAS No. :
115746-69-5
Molecular Formula :
C22H22O11
Molecular Weight :
462.41

IUPAC Name:(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((3-phenylacryloyl)oxy)methyl)tetrahydro-2H-pyran-2-yl 3,4,5-trihydroxybenzoate

(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(((3-phenylacryloyl)oxy)methyl)tetrahydro-2H-pyran-2-yl 3,4,5-trihydroxybenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(((3-phenylacryloyl)oxy)methyl)tetrahydro-2H-pyran-2-yl 3,4,5-trihydroxybenzoate
IUPAC Name(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((3-phenylacryloyl)oxy)methyl)tetrahydro-2H-pyran-2-yl 3,4,5-trihydroxybenzoate
Molecular FormulaC22H22O11
Molecular Weight462.41
SMILESO=C(C=CC1=CC=CC=C1)OC[C@H]1O[C@@H](OC(=O)C2=CC(O)=C(O)C(O)=C2)[C@H](O)[C@@H](O)[C@@H]1O
InChI KeyREBRERQNUHGTMS-PGPONNFDSA-N
Synonym1-O-galloyl-6-O-cinnamoylglucose;β-D-Glucopyranose, 6-[(2E)-3-phenyl-2-propenoate] 1-(3,4,5-trihydroxybenzoate);1-O-galloyl-6-O-cinnamoyl-β-D-glucose
CAS No.115746-69-5

Synthetic Route by SureRoute

1. ACMNZL328 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACERPW593 route compound structure diagram
    ACERPW59313405-60-2 In Stock
  4. Then
  5. ACMNZL328 route product structure diagram
    ACMNZL328115746-69-5
Inquiry

2. ACMNZL328 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACERPW593 route compound structure diagram
    ACERPW59313405-60-2 In Stock
  4. Then
  5. ACMNZL328 route product structure diagram
    ACMNZL328115746-69-5
Inquiry

Comments (0)